British Regulator Approves Pfizer-BioNTech COVID-19 Vaccine for 12-Year-Olds
Britain’s Medicines and Healthcare products Regulatory Agency on Friday approved the Pfizer-BioNTech COVID-19 vaccine for 12- to 15-year-olds. The decision follows similar approvals by U.S.